ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

RLFTY Relief Therapeutics Holding SA (QB)

1.4006
0.00 (0.00%)
May 06 2024 - Closed
Delayed by 15 minutes

Period:

Draw Mode:

Volume 0.00
Bid Price 1.12
Ask Price 1.58
News -
Share Name Share Symbol Market Stock Type
Relief Therapeutics Holding SA (QB) RLFTY OTCMarkets Depository Receipt
  Price Change Price Change % Share Price Last Trade
0.00 0.00% 1.4006 12:29:13
Open Price Low Price High Price Close Price Previous Close
1.4006 1.4006
Trades Shares Traded Average Volume
0 0.00 -
Last Trade Type Quantity Price Currency
- 0  1.4006 USD

Relief Therapeutics Holding SA (QB) Financials

Market Cap Shares in Issue Float Revenue Profit/Loss EPS PE Ratio
 15.43M 11.02M 7.91M - -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- - - -

more financials information »

News Relief Therapeutics (QB)

Real-Time news about Relief Therapeutics Holding SA (QB) (OTCMarkets): 0 recent articles
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No RLFTY Message Board. Create One! See More Posts on RLFTY Message Board See More Message Board Posts

RLFTY Historical

Period † Open High Low VWAP Avg. Daily Vol Change %
1 Week0.000.000.000.0000.000.00%
1 Month0.000.000.000.0000.000.00%
3 Months0.000.000.000.0000.000.00%
6 Months0.000.000.000.0000.000.00%
1 Year0.000.000.000.0000.000.00%
3 Years0.000.000.000.0000.000.00%
5 Years0.000.000.000.0000.000.00%

Relief is a Swiss, commercial-stage, biopharmaceutical company focused on identification, development and commercialization of novel, patent protected products intended for the treatment of rare and ultra-rare diseases including metabolic disorders, pulmonary diseases, and connective tissue disorders. The parent company of the group, RELIEF THERAPEUTICS Holding SA, is listed on the SIX Swiss Exchange under the symbol RLF and quoted in the U.S. on OTCQB under the symbols RLFFD and RLFTD.

Your Recent History

Delayed Upgrade Clock